GB0125764D0 - Diagnosis of cervicasl cancer - Google Patents

Diagnosis of cervicasl cancer

Info

Publication number
GB0125764D0
GB0125764D0 GB0125764A GB0125764A GB0125764D0 GB 0125764 D0 GB0125764 D0 GB 0125764D0 GB 0125764 A GB0125764 A GB 0125764A GB 0125764 A GB0125764 A GB 0125764A GB 0125764 D0 GB0125764 D0 GB 0125764D0
Authority
GB
United Kingdom
Prior art keywords
cervicasl
diagnosis
cancer
cervicasl cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0125764A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University College London
Original Assignee
University College London
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University College London filed Critical University College London
Priority to GB0125764A priority Critical patent/GB0125764D0/en
Publication of GB0125764D0 publication Critical patent/GB0125764D0/en
Priority to PCT/GB2002/004887 priority patent/WO2003036300A2/en
Ceased legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57411—Specifically defined cancers of cervix
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/708—Specific hybridization probes for papilloma
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Hospice & Palliative Care (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • General Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
GB0125764A 2001-10-26 2001-10-26 Diagnosis of cervicasl cancer Ceased GB0125764D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GB0125764A GB0125764D0 (en) 2001-10-26 2001-10-26 Diagnosis of cervicasl cancer
PCT/GB2002/004887 WO2003036300A2 (en) 2001-10-26 2002-10-28 Diagnosis of cervical cancer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0125764A GB0125764D0 (en) 2001-10-26 2001-10-26 Diagnosis of cervicasl cancer

Publications (1)

Publication Number Publication Date
GB0125764D0 true GB0125764D0 (en) 2001-12-19

Family

ID=9924611

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0125764A Ceased GB0125764D0 (en) 2001-10-26 2001-10-26 Diagnosis of cervicasl cancer

Country Status (2)

Country Link
GB (1) GB0125764D0 (en)
WO (1) WO2003036300A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060024722A1 (en) * 2004-07-30 2006-02-02 Mark Fischer-Colbrie Samples for detection of oncofetal fibronectin and uses thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1151094A1 (en) * 1998-12-07 2001-11-07 University College London Cervical cancer treatment

Also Published As

Publication number Publication date
WO2003036300A3 (en) 2003-10-30
WO2003036300A2 (en) 2003-05-01

Similar Documents

Publication Publication Date Title
IL251270A0 (en) Cancer treatment
IL159344A0 (en) Quinuclidines-substituted-multicyclic-heteroaryls for the treatment of disease
AU2002251844A1 (en) Compositions and methods for the therapy and diagnosis of colon cancer
HUP0400314A3 (en) Pharmaceutical combinations for the treatment of cancer
EP1457157A4 (en) Ultrasonograph
AU2002246519A8 (en) Compositions and methods for the therapy and diagnosis of colon cancer
EP1461027A4 (en) Treatment of neoplasia
EP1420814A4 (en) Compositions and methods for the therapy and diagnosis of breast cancer
HUP0500734A3 (en) Use of 2-alkoxyphenyl-substituted imidazotriazinones
EP1411357A4 (en) Cancer diagnostics
EP1380840A4 (en) Method of diagnosing breast cancer
AU2002253899A1 (en) Compositions and methods for the therapy and diagnosis of breast cancer
EP1434593A4 (en) MODIFICATIONS OF SOLID 3-sn-PHOSPHOGLYCERIDES
EP1409734A4 (en) Diagnosis and treatment of cancer
AU2002360815A8 (en) Human breast cancer biomarkers
AU2002332606A8 (en) Compositions and methods for the therapy and diagnosis of colon cancer
GB0125764D0 (en) Diagnosis of cervicasl cancer
GB0129452D0 (en) Diagnosis of cancer
GB0122410D0 (en) Cancer diagnosis
EP1463511A4 (en) Combination cancer therapy
EP1616190A4 (en) Diagnosis of advanced cancer
IL147416A0 (en) Combined modalities for improved cancer treatment
AU2002337330A1 (en) Diagnosis of cervical cancer
GB0129451D0 (en) Treatment of cancer
GB0105222D0 (en) Diagnosis of dyslexia

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)